COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/24/2026
Back to search
Official data from USPTO
APEX MD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APEX MD
ST13
US500000099345278Class
5, 35, 44
Filing
99345278
Registration
8186121
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/24/2026
Trademark type
Word
Nice classes
5, 35, 44
Filing date
08/19/2025
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
07/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2024-11-00
First use in commerce
2024-11-00
Drawing code
4
Owner type
16
Owner location
Orlando, FL, US
Examiner
RENNEKER, CHRISTOPHER JOHN
Current location
Historical data usage
Holders and representatives
Holders
Apex Health Holdings LLC
Representatives
Joshua M. Gerben Gerben Perrott, PLLC
Technical classification
Nice Classes
Class 5Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for weight managementweight loss and the maintenance of weight loss; Pharmaceutical preparations for testosterone replacement therapylongevity peptideshormone replacement therapy
Class 35
On-line retail store services featuring pharmaceuticals for weight managementweight loss and the maintenance of weight loss; Pharmaceutical servicesprocessing online and telephone prescription orders in retail and central fill pharmacies; Subscription-based order fulfillment services in the field of pharmaceuticals for weight managementweight loss and the maintenance of weight loss; On-line retail store services featuring pharmaceuticals for testosterone replacement therapylongevity peptideshormone replacement therapy; Subscription-based order fulfillment services in the field of pharmaceuticals for testosterone replacement therapylongevity peptideshormone replacement therapy
Class 44
Medical care and pharmaceutical care consultation services; Nutrition consultation services for weight loss; Health care serviceswellness programs; Nutrition counseling; Providing medical advice in the field of weight managementweight loss and the maintenance of weight loss; Providing health information in the field of dietnutritionweight managementweight loss and the maintenance of weight loss; Weight management servicesproviding weight loss and/or weight maintenance programs; Medical servicestelehealth services in the field of weight lossweight managementprescription consultationnutritional counseling; Providing medical advice in the field of testosterone replacement therapypreventative medicinelongevity peptideshormone replacement therapy; Providing health information in the field of testosterone replacement therapypreventative medicinelongevity peptideshormone replacement therapy; all of the foregoing excluding business consulting services
Publications
History of USPTO decisions and trademark events.
20 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/13/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
04/14/2026
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
04/12/2026
APET
ASSIGNED TO PETITION STAFF
04/10/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2026
PUBO
PUBLISHED FOR OPPOSITION
02/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/28/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/08/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/08/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/08/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/08/2026
DOCK
ASSIGNED TO EXAMINER
01/08/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2026
MAFR
APPLICATION FILING RECEIPT MAILED
08/19/2025
NWAP
NEW APPLICATION ENTERED
08/19/2025
Continuous trademark protection
Get notified about every new filing that threatens APEX MD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.